Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today provided an update …
Roth Capital’s healthcare analysts weigh in on biotech stocks Catalyst Pharmaceuticals Inc (NASDAQ:CPRX) and bluebird bio Inc (NASDAQ:BLUE). While Catalyst pharma received a “Refusal to File” letter from …
The iShares Nasdaq Biotechnology ETF (NASDAQ:IBB), which tracks 144 biotech and pharmaceutical companies, climbed nearly 3% today, four-day win streak, helped by some encouraging …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that the …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced the initiation …
Healthcare analysts weighed in today on small-cap biotech companies Advaxis, Inc. (NASDAQ:ADXS) and Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), with positive ratings.
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, announced today the completion …
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced top line …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today reported financial results …
Catalyst Pharmaceuticals Inc (NASDAQ:CPRX), a biopharmaceutical company focused on developing and commercializing innovative therapies for people with rare debilitating diseases, today announced that Barbara …
